Product description
KLOW is an advanced multi-peptide research complex incorporating KPV, BPC-157, GHK-Cu, and TB-500. This multi-target compound is synthesized specifically for preclinical trials focused on balancing severe cellular inflammatory cascades while accelerating structural tissue matrix synthesis.
Primary research focus
-
Inflammatory Signaling Regulation
Researched for its multi-targeted inhibition of pro-inflammatory pathways (including NF-κB).
-
Comprehensive Tissue Repair
Evaluated across connective, epithelial, and vascular cell culture models.
-
Systemic Cellular Homeostasis
Investigated in complex organ and tissue models requiring simultaneous anti-inflammatory and regenerative stimuli.

